GlaxoSmithKline, Emergent BioSolutions test Ebola vaccines

Posted by Leanne Kodsman on

According to FierceBiotech's March 18 article, GlaxoSmithKline (GSK) is testing out an Ebola vaccine in Africa. It is interested to find out if an immune reaction strong enough to overcome Ebola will occur.

If no strong immune response occurs, GSK will test Emergent BioSolutions' Ebola shot as a booster to their own vaccination. The two companies have partnered in this endeavor in Phase I trials at the University of Oxford.


According to FierceBiotech's March 18 article, GlaxoSmithKline (GSK) is testing out an Ebola vaccine in Africa. It is interested to find out if an immune reaction strong enough to overcome Ebola will occur.

If no strong immune response occurs, GSK will test Emergent BioSolutions' Ebola shot as a booster to their own vaccination. The two companies have partnered in this endeavor in Phase I trials at the University of Oxford.

Emergent, based in Maryland, announced that through partnerships with several different companies it was able to create an Ebola candidate called a modified vaccinia Ankara Ebola Zaire vaccine, or MVA EBOZ.

Emergent's candidate was produced using a scalable process which means it could be mass produced to meet demands for large numbers of doses.

Only Merck and NewLink are currently testing their candidates in Africa.


    Innovative Research was established in 1998 after the realization that dependable, high-quality, and affordable research materials were hard to come by. Starting with core products like human plasma and serum, Innovative Research has grown to be a trusted supplier of all lab reagents, including human biologicals and ELISA kits. Today, we manufacture and supply thousands of high-quality human and animal biologicals including plasma, serum, tissues, and proteins.


Related Posts

Innovative Research Forms Strategic Partnership with Bioz
Innovative Research is pleased to announce a strategic partnership with Bioz, Inc., a l...
Read the Article
GLP-1 Drugs: A Paradigm Shift in Obesity Treatment
We have entered a new era in the world of obesity treatment, with a clear and distinct ...
Read the Article
5 End-of-Year Promotions You Don’t Want to Miss from Innovative Research
As the year 2023 ends, we at Innovative Research want to thank you for your continued s...
Read the Article

← Older Post Newer Post →

×